What is GHK-Cu
GHK is a tripeptide: glycine, histidine, and lysine joined in sequence. The imidazole ring on the histidine residue gives the molecule high affinity for copper(II) ions, forming a stable complex at physiological pH. Pickart first isolated it from human albumin in 1973 while investigating a plasma factor that stimulated aged liver tissue to synthesize proteins at rates resembling younger tissue.
GHK appears in human plasma, urine, and saliva. Plasma concentrations decline with age: roughly 200 ng/mL at age 20 and 80 ng/mL by age 60, according to review data published by Pickart in the Journal of Biomaterial Science (Pickart, 2008). That decline parallels a reduction in wound-healing rate and skin regenerative capacity, though no human intervention study has established direct causality between circulating GHK-Cu levels and tissue repair outcomes.
The GHK tripeptide sequence also appears in the alpha-2 chain of type I collagen. Proteases acting on damaged collagen at wound sites may liberate the tripeptide in situ, which would make it a locally generated repair signal as well as a circulating one. Research-grade GHK-Cu is available as a lyophilized powder from Zurich Biotech.
Mechanism: copper delivery and ECM regulation
GHK-Cu is a copper delivery vehicle by the leading mechanistic model. Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin to give connective tissue its tensile strength; for ceruloplasmin, which oxidizes ferrous iron; and for Cu/Zn superoxide dismutase, a primary cellular antioxidant. Delivering copper to fibroblasts and tissue cells enables several downstream repair processes simultaneously.
In dermal fibroblast cultures, GHK-Cu stimulated collagen synthesis in a concentration-dependent pattern. Stimulation began at concentrations between 10-12 and 10-11 M and reached a maximum at 10-9 M, with no change in cell number across the effective range. The authors concluded the effect was a genuine synthetic stimulus rather than a secondary consequence of cell proliferation (Maquart et al., 1988, FEBS Lett, in vitro fibroblast cultures).
The same complex also raises MMP-2 (matrix metalloproteinase-2) levels in fibroblast conditioned media, while simultaneously increasing TIMP-1 and TIMP-2 (tissue inhibitors of metalloproteinases) (Maquart et al., 2004, in vitro). The net outcome is regulated ECM turnover: MMP-2 removes damaged collagen, TIMPs prevent runaway degradation. This dual regulation is why researchers frame GHK-Cu as a remodeling regulator rather than a simple synthesis booster.
Cell culture work also shows that GHK-Cu increases secretion of VEGF, nerve growth factor, and FGF, and attracts both immune cells and endothelial cells to injury sites. Whether these signaling effects translate at physiologically relevant concentrations in intact human tissue has not been tested directly.
GHK-Cu research in animal wound healing models
Most wound-healing evidence comes from rodent and rabbit models. In rabbit experimental wounds, topical GHK-Cu improved wound contraction, raised granulation tissue formation, increased antioxidant enzyme activity, and raised blood vessel density at the wound site compared to untreated controls. These differences were measurable within the first week of treatment in published protocols.
A rat model specifically examined wound healing in tissue damaged by prior radiation exposure, a condition that compromises vascularity and slows normal repair. Topical GHK-Cu complex improved clinical and histological healing endpoints compared to control animals (Parker et al., 2013, Otolaryngology-Head and Neck Surgery, rat model). The radiation-impaired healing scenario is relevant to post-radiotherapy surgical complications in clinical practice. Species differences and dose translation from rat data to other contexts remain real limitations of this evidence.
Earlier rodent implantation studies confirmed in vivo connective tissue accumulation: collagen and glycosaminoglycan content were higher in GHK-Cu-treated wound beds than in untreated ones, measured directly from tissue samples.
As of mid-2026, no registered randomized controlled trials in human wound healing had reported results with GHK-Cu as the intervention.
Skin and dermatology evidence
Skin evidence is more developed than the wound-healing literature, partly because cosmetics companies have funded work on copper peptides as anti-aging ingredients for over two decades.
Before any topical agent can do anything useful in skin, it has to get past the stratum corneum. In vitro penetration studies on human skin found that GHK-Cu does reach viable epidermis and dermis. Applied to split-thickness skin, roughly 2% of the applied dose was measured in deeper layers; about 20% was retained in the stratum corneum itself (PMC3016279, 2010, human skin in vitro model). Plain aqueous solutions penetrate poorly through intact epidermis; liposomal encapsulation raises delivery to deeper layers substantially.
A 12-week study on thigh skin in women compared topical GHK-Cu, vitamin C cream, and retinoic acid. Collagen production improved in 70% of GHK-Cu-treated subjects, compared with 50% for vitamin C and 40% for retinoic acid, assessed by skin biopsy. Increases in skin thickness, hydration, and elasticity were reported alongside the collagen data. These figures appear in review articles by Pickart and colleagues rather than in an independently registered trial with a public protocol; independent replication has not been published.
A 2015 review by Pickart, Vasquez-Soltero, and Margolina compiled the cell biology and skin evidence, identifying at least 12 cellular pathways potentially relevant to skin regeneration that GHK-Cu may modulate (Pickart et al., 2015, Biomedical Research International, review). The breadth of the mechanistic map is plausible given the MMP and collagen data; the depth of human evidence for most pathways on that list is limited.
Gene expression findings
A 2018 paper by Pickart and Margolina used publicly available gene expression databases and connectivity mapping to estimate which biological programs GHK-Cu might regulate across cell types (Pickart and Margolina, 2018, International Journal of Molecular Sciences). The analysis identified potential modulation of genes in inflammation control, collagen assembly, antioxidant defense, and nerve function, spanning several hundred targets across multiple pathways.
In silico connectivity analysis generates hypotheses; it does not confirm effects in human cells or tissue. The 2018 paper is explicit about this scope. Researchers citing specific pathway claims from that analysis should read the primary text to understand what was measured versus what was inferred computationally.
A 2017 analysis examined GHK's effects on gene networks relevant to cognitive decline, finding modulation of genes associated with ubiquitin-proteasome function, synaptic transmission, and oxidative stress. This is preliminary mechanistic data on a potential neuroprotective hypothesis, at a considerable remove from clinical evidence.
Storage and handling for research use
Lyophilized GHK-Cu is stable at -20°C in a dry, light-protected environment. Manufacturers typically state a shelf life of 2 years under these conditions, consistent with published stability data for lyophilized tripeptides generally. Once reconstituted in bacteriostatic water, GHK-Cu solution should be used within 4 to 6 weeks when stored at 2-8°C.
For researchers in Indonesia, where ambient temperatures regularly exceed 30°C and relative humidity routinely exceeds 70%, maintaining cold-chain integrity from receipt through reconstitution is the main practical variable. The copper-peptide complex is not uniquely vulnerable to tropical humidity compared to other lyophilized peptides, but all the ICH Zone IV stability risks documented for lyophilized compounds apply here. The lyophilized peptide storage guide covers the Zone IV conditions relevant to Bali and Jakarta in detail, including two-tier freezer setups that work in residential settings.
For reconstitution steps and bacteriostatic water selection, see the peptide reconstitution protocol. To calculate syringe volume and concentration for a GHK-Cu vial, use the dosing calculator.